Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Response Rates to Newest Antidepressants Reach 50-70%: JSMD Symposium
July 19, 2004
- Iryo Proverbs Reveal Japanese Spirit (21)
July 12, 2004
- 1st Qtr Business Results
July 12, 2004
- Korosho's WG on Anti-cancer Combination Therapies Approves 2 Reports
July 12, 2004
- JCQHC Sets Up Medical Accident Prevention Center
July 12, 2004
- Eli Lilly Japan Aims at 20th Place by 2010: Mr Crenshaw
July 12, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 12, 2004
- Siebel Confident on Domestic Prospects for CRM Business
July 12, 2004
- Chugai R&D Focuses on Low-Molecular-Weight Agonist Antibodies
July 12, 2004
- Policy Promotion HQ Sets Up Coordinators' Group
July 12, 2004
- Takeda, AnGes MG, Sato Sports Join "22nd Century Medical Center" Project
July 12, 2004
- REGULATORY NEWS IN BRIEF
July 12, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
July 12, 2004
- Generics Offer Economic Benefits to Patients, Med Institutions: Utobrain Seminar
July 12, 2004
- PRESS SEMINAR
July 12, 2004
- Taiyo Pharm Conducts Tour of Takayama Plant
July 12, 2004
- Nihon Medi-physics: Benzodine Inj. for Imaging of Epileptic Focus
July 12, 2004
- EPMA Considers Affiliation with IGPA
July 12, 2004
- Use of AED by the General Public Should Be Promoted: JHF Seminar
July 12, 2004
- Number of e-Details with MR-kun Exceeds 1.1 Mil. per Qtr
July 12, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…